Chromosomal instability in the lymphocytes of breast cancer patients.
Genomic instability in the tumor tissue has been correlated with tumor progression. In the present study, chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) of breast tumor patients were studied to assess whether chromosomal instability (CIN) in PBLs correlates with aggressiveness of breast tumor (i.e., disease stage) and has any prognostic utility. Cultured blood lymphocyte metaphases were scored for aberrations in 31 breast cancer patients and 20 healthy age and sex-matched controls. A variety of CAs, including aneuploidy, polyploidy, terminal deletions, acentric fragments, double minutes, chromatid separations, ring chromosome, marker chromosome, chromatid gaps, and breaks were seen in PBLs of the patients. The CAs in patients were higher than in controls. A comparison of the frequency of metaphases with aberrations by grouping the patients according to the stage of advancement of disease did not reveal any consistent pattern of variation in lymphocytic CIN. Neither was any specific chromosomal abnormality found to be associated with the stage of cancer. This might be indicative of the fact that cancer patients have constitutional CIN, which predisposes them to the disease, and this inherent difference in the level of genomic instability might play a role in disease progression and response to treatment.
Harsimran
Kaur
K
Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab-143 005, India.
Kaur
Monga Gaganpreet
MG
Nitika
Setia
S
Meena
Sudan
S
M S
Uppal
U
Yamini
A P S
Batra
B
Vasudha
Sambyal
S
Oncol Rep. 2001 Sep-Oct;8(5):1001-5
11496305
Anticancer Res. 1991 May-Jun;11(3):1055-60
1888138
Trends Cell Biol. 1999 Dec;9(12):M57-60
10611684
Epidemiology. 2004 Jul;15(4):442-50
15232405
Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):533-7
11173151
BMJ. 2000 Sep 9;321(7261):624-8
10977847
Environ Health Perspect. 2005 May;113(5):517-20
15866756
Cytogenet Genome Res. 2004;104(1-4):376-82
15162068
Ann Genet. 1994;37(4):192-5
7710254
J Cell Biol. 2008 Feb 25;180(4):665-72
18283116
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5770-5
11296254
Hum Genet. 1991 Nov;88(1):39-41
1959924
Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):783-9
9752986
Nat Rev Cancer. 2001 Nov;1(2):109-17
11905802
Cancer. 1999 Jun 1;85(11):2400-9
10357411
Ann Surg. 2001 Dec;234(6):795-802; discussion 802-3
11729386
Mutat Res. 2008 Mar 12;651(1-2):93-104
18093868
Environ Health Perspect. 1993 Oct;101 Suppl 3:169-75
7511527
Am J Epidemiol. 2007 Jan 1;165(1):36-43
17071846
Nat Genet. 2004 Sep;36(9):984-8
15300252
Hum Pathol. 2000 Feb;31(2):201-7
10685634
Nat Rev Cancer. 2004 Apr;4(4):266-76
15057286
Exp Cell Res. 1960 Sep;20:613-6
13772379
Breast Cancer Res Treat. 1998 Mar;48(2):187-90
9596490
Epidemiol Rev. 1993;15(1):36-47
8405211
Cancer Res. 2004 Mar 15;64(6):2258-63
15026371
Int J Oncol. 2000 Aug;17(2):399-404
10891553